RyplazimRyplazim can be the first to go on after the signature of the Bill because the FDA DIDN'T REFUSE the product.They simply asked for more check points.They are on the calendar of the FDA to acceptance this fall after new batch production.They continue injection on the patient.
RYPLAZIM has the profile of an accepted product (not even a drug but a natural product coming from our plasma).